CABA
Price
$1.21
Change
+$0.05 (+4.31%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
58.86M
6 days until earnings call
IOVA
Price
$3.16
Change
+$0.03 (+0.96%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.05B
90 days until earnings call
Ad is loading...

CABA vs IOVA

Header iconCABA vs IOVA Comparison
Open Charts CABA vs IOVABanner chart's image
Cabaletta Bio
Price$1.21
Change+$0.05 (+4.31%)
Volume$2.52K
Capitalization58.86M
Iovance Biotherapeutics
Price$3.16
Change+$0.03 (+0.96%)
Volume$287.9K
Capitalization1.05B
CABA vs IOVA Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. IOVA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and IOVA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (CABA: $1.16 vs. IOVA: $3.13)
Brand notoriety: CABA and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 47% vs. IOVA: 83%
Market capitalization -- CABA: $58.86M vs. IOVA: $1.05B
CABA [@Biotechnology] is valued at $58.86M. IOVA’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileIOVA’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • IOVA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CABA and IOVA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 4 bearish.
  • IOVA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а -12.12% price change this week, while IOVA (@Biotechnology) price change was -12.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

CABA is expected to report earnings on Aug 07, 2025.

IOVA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($1.05B) has a higher market cap than CABA($58.9M). CABA YTD gains are higher at: -48.899 vs. IOVA (-57.703). CABA has higher annual earnings (EBITDA): -112.92M vs. IOVA (-351.67M). IOVA has more cash in the bank: 324M vs. CABA (183M). CABA has less debt than IOVA: CABA (15.2M) vs IOVA (58.3M). IOVA has higher revenues than CABA: IOVA (164M) vs CABA (0).
CABAIOVACABA / IOVA
Capitalization58.9M1.05B6%
EBITDA-112.92M-351.67M32%
Gain YTD-48.899-57.70385%
P/E RatioN/AN/A-
Revenue0164M-
Total Cash183M324M56%
Total Debt15.2M58.3M26%
FUNDAMENTALS RATINGS
IOVA: Fundamental Ratings
IOVA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAIOVA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 22 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLCX16.220.01
+0.06%
MFS Global Real Estate C
LZSIX11.51N/A
N/A
Lazard International Equity Select Instl
OTCCX20.30N/A
N/A
MFS Mid Cap Growth C
QABGX21.32N/A
N/A
Federated Hermes MDT Balanced A
GITIX33.75N/A
N/A
Goldman Sachs Technology Opps Inst

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+0.87%
KYTX - CABA
47%
Loosely correlated
+0.50%
IMNM - CABA
44%
Loosely correlated
-2.56%
ARWR - CABA
43%
Loosely correlated
-0.15%
PRME - CABA
41%
Loosely correlated
+6.77%
IPSC - CABA
41%
Loosely correlated
-1.55%
More